Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

Ya Luo, Ya-Zhen Qin, Xiaosu Zhao, Ying-Jun Chang, Jing Liu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Meng Lv

Blood (2025) 146 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2025-3518

Published: 2025

Journal Articles

FLT3-ITD drives poor prognosis in NPM1 mutated AML via BCAT1-dependent epigenetic regulation

Kainan Zhang, Xiaohang Ma, Xiaoxuan Lu, Guorui Ruan, Fangfang Wei, Hao Jiang, Xiaojun Huang, Xiaosu Zhao

Blood (2025) 146 (Supplement 1): 5003.

https://doi.org/10.1182/blood-2025-5003

Published: 2025

Journal Articles

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Guanghui Chang, Haitao Gao, Qiang Fu, Xiaosu Zhao, Yu Wang, Qian Jiang, Hao Jiang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Feifei Tang

Blood (2025) 146 (Supplement 1): 5163.

https://doi.org/10.1182/blood-2025-5163

Published: 2025

Journal Articles

Safety and efficacy of venetoclax plus CAG (cytarabine, aclarubicin, G-CSF) regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective single-arm phase II study

Wen-Jing Yu, Wen-Bing Duan, Qi Chen, Xuying Pei, Jinsong JIA, Jing Wang, Xiaolu Zhu, Xiaosu Zhao, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 1680.

https://doi.org/10.1182/blood-2025-1680

Published: 2025

Journal Articles

Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial

Xiaolu Zhu, Zhao Ting, Wen-Bing Duan, Qi Chen, Jing Liu, Wen-Jing Yu, Xiaosu Zhao, Ya-Zhen Qin, Hong-Xia Shi, Ying-Jun Chang, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 1671.

https://doi.org/10.1182/blood-2025-1671

Published: 2025

Journal Articles

Vennetoclax combined with decitabine, cytarabine, aclacinomycin and granulocyte colony-stimulating factor as induction regimen achieved high response rate in newly diagnosed adverse risk Acute Myeloid Leukemia

Wenbing Duan, Ying Wu, Wen-Jing Yu, Qi Chen, Zhao Ting, Jing Liu, Le-Qing Cao, Ying-Jun Chang, Xiaosu Zhao, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 1611.

https://doi.org/10.1182/blood-2025-1611

Published: 2025

Journal Articles

Oral VP16 combined with ATRA and realgar-indigo naturalis formula as complete oral induction regimen is an fast，safe and effective regimen during induction to reduce mortality in high-risk acute promyelocytic leukemia

Wenbing Duan, Qi Chen, Wen-Jing Yu, Xiaolu Zhu, Jing Liu, Zhao Ting, Xiaosu Zhao, Ya-Zhen Qin, Guorui Ruan, Ying-Jun Chang, Xiaojun Huang, Hao Jiang

Blood (2025) 146 (Supplement 1): 6966.

https://doi.org/10.1182/blood-2025-6966

Published: 2025

Journal Articles

Integrating EVI1 expression into prognostic models for MDS: Insights from IPSS-R and IPSS-m subgroup analyses

Xiaohang Ma, Wen-Bing Duan, Qi Chen, Ya-Zhen Qin, Hao Jiang, Qian Jiang, Ying-Jun Chang, Xiaojun Huang, Xiaosu Zhao

Blood (2025) 146 (Supplement 1): 3479.

https://doi.org/10.1182/blood-2025-3479

Published: 2025

Journal Articles

Exploring the Prognostic Significance of Graft CD161-Expressing T Cells in Allo-HSCT

Gao Mengge, Ying-Jun Chang, Xiao Jun Huang, Xiaosu Zhao

Blood (2024) 144 (Supplement 1): 7103.

https://doi.org/10.1182/blood-2024-207173

Published: 2024

Journal Articles

Parvovirus B19 Originates from Infected Hematopoietic Stem Cells Following Hematopoietic Stem Cell Transplantation

Xuying Pei, Xiaojun Huang, Zhuojun Liu, Qiang Fu, Xiaosu Zhao, Yuqian Sun

Blood (2024) 144 (Supplement 1): 690.

https://doi.org/10.1182/blood-2024-206539

Published: 2024

Journal Articles

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Menglin Li, HaiXia Fu, Hui Liu, Ru Feng, Yi Liu, Jingwen Wang, Lei Yang, Zhao Wang, Gaochao Zhang, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Lulu Wang, Mengtong Zang, Yun He, Xiaolu Zhu, Xiaosu Zhao, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 712.

https://doi.org/10.1182/blood-2024-198335

Published: 2024

Journal Articles

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Menglin Li, Yi-Meng Li, Qingyuan Qu, Yuxiu Chen, Jianying Zhou, Mengyu Xiao, Chencong Wang, Qi Chen, Xiaolu Zhu, Yun He, YuanYuan Zhang, Qian Jiang, Hao Jiang, Jin Lu, YingJun Chang, Xiaosu Zhao, Xiangyu Zhao, Xiao Jun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 1486.

https://doi.org/10.1182/blood-2024-204777

Published: 2024

Journal Articles

The Well Tolerated VA-Based Regimen Bringing to High Quality of Life Did Not Absolutely Inferior to Intensive Chemotherapy in AML Patients with NPM1 Mutation

Wenbing Duan, Qi Chen, WenJing Yu, Jinsong Jia, Jing Wang, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang

Blood (2024) 144 (Supplement 1): 5952.

https://doi.org/10.1182/blood-2024-206400

Published: 2024

Journal Articles

Impact of FLT3-ITD Molecular Characteristics on the Prognosis of Patients with De Novo Acute Myeloid Leukemia

Kainan Zhang, Xiaohang Ma, Xiaoxuan Lu, Guo-rui Ruan, Fangfang Wei, Hao Jiang, Xiao Jun Huang, Xiaosu Zhao

Blood (2024) 144 (Supplement 1): 5940.

https://doi.org/10.1182/blood-2024-201537

Published: 2024

Journal Articles

Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia

Xiaolu Zhu, Feifei Tang, Wenjing Yu, Xiaosu Zhao, Yazhen Qin, Qian Jiang, Xiao Jun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 1481.

https://doi.org/10.1182/blood-2023-180002

Published: 2023

Journal Articles

G-CSF Induces MAIT Cells to Exert Anti-Intestinal Gvhd Effects Dependent on CXCR6 Mediated Chemotaxis

Gao Mengge, Jun Kong, Yuqian Sun, Zhidong Wang, Ting-Ting Han, Yu Wang, Xiaosu Zhao, Xiao Jun Huang

Blood (2023) 142 (Supplement 1): 2048.

https://doi.org/10.1182/blood-2023-181445

Published: 2023

Journal Articles

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Lizhong Gong, WenJing Yu, Xiaolu Zhu, Zhao Ting, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Yu Wang, Hongxia Shi, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 4309.

https://doi.org/10.1182/blood-2023-184769

Published: 2023

Journal Articles

Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study

Xiaohong Liu, Yao Li, Wenjing Yu, Xiaolu Zhu, Jinsong Jia, Lizhong Gong, Xiaosu Zhao, Yingjun Chang, Xiao-Jun Huang, Hao Jiang

Blood (2022) 140 (Supplement 1): 3299–3300.

https://doi.org/10.1182/blood-2022-168422

Published: 2022

Journal Articles

Exploring the Effects of G-CSF Mobilization on the Immune Function of Mucosal-Associated Invariant T Cell Subsets By Single-Cell RNA-Seq

Gao Mengge, Jun Kong, Yuqian Sun, Zhidong Wang, Ting-Ting Han, Meng Lyu, Yu Wang, Xiaosu Zhao, Xiao Jun Huang

Blood (2022) 140 (Supplement 1): 7352–7354.

https://doi.org/10.1182/blood-2022-164926

Published: 2022

Journal Articles

Prognostic Impact of WT1 Mutation on AML of Different Risk Groups Based on 2022 European Leukemianet (ELN) Risk Classification

Xinan Pan, Gao Mengge, Ke Wang, Yu Wang, Jun Kong, Yuqian Sun, Xiaosu Zhao, Xiao Jun Huang

Blood (2022) 140 (Supplement 1): 3216–3217.

https://doi.org/10.1182/blood-2022-166323

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

FLT3-ITD drives poor prognosis in NPM1 mutated AML via BCAT1-dependent epigenetic regulation

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Safety and efficacy of venetoclax plus CAG (cytarabine, aclarubicin, G-CSF) regimen in patients with relapsed or refractory Acute Myeloid Leukemia: A prospective single-arm phase II study

Oral etoposide vs intravenous daunorubicin plus ATRA-RIF as induction therapy for low-risk acute promyelocytic leukemia: A phase II randomized controlled Trial

Vennetoclax combined with decitabine, cytarabine, aclacinomycin and granulocyte colony-stimulating factor as induction regimen achieved high response rate in newly diagnosed adverse risk Acute Myeloid Leukemia

Oral VP16 combined with ATRA and realgar-indigo naturalis formula as complete oral induction regimen is an fast，safe and effective regimen during induction to reduce mortality in high-risk acute promyelocytic leukemia

Integrating EVI1 expression into prognostic models for MDS: Insights from IPSS-R and IPSS-m subgroup analyses

Exploring the Prognostic Significance of Graft CD161-Expressing T Cells in Allo-HSCT

Parvovirus B19 Originates from Infected Hematopoietic Stem Cells Following Hematopoietic Stem Cell Transplantation

Updated Outcome from Biomarker MSC-C5b-9-Guided All-Trans Retinoic Acid Treatment for Resistant/Recurrent ITP: A Multicenter, Randomized, Open-Label, Phase 3 Clinical Trial

Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

The Well Tolerated VA-Based Regimen Bringing to High Quality of Life Did Not Absolutely Inferior to Intensive Chemotherapy in AML Patients with NPM1 Mutation

Impact of FLT3-ITD Molecular Characteristics on the Prognosis of Patients with De Novo Acute Myeloid Leukemia

Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia

G-CSF Induces MAIT Cells to Exert Anti-Intestinal Gvhd Effects Dependent on CXCR6 Mediated Chemotaxis

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study

Exploring the Effects of G-CSF Mobilization on the Immune Function of Mucosal-Associated Invariant T Cell Subsets By Single-Cell RNA-Seq

Prognostic Impact of WT1 Mutation on AML of Different Risk Groups Based on 2022 European Leukemianet (ELN) Risk Classification

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only